Works matching IS 21989788 AND DT 2019 AND VI 6 AND IP 1
Results: 5
Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 1, p. 27, doi. 10.1007/s40801-019-0150-8
- By:
- Publication type:
- Article
Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A Single-Center Experience.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 1, p. 19, doi. 10.1007/s40801-019-0149-1
- By:
- Publication type:
- Article
Epidemiological Profile of Drug Overdose Reported in South-East Morocco from 2004 to 2016.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 1, p. 11, doi. 10.1007/s40801-019-0148-2
- By:
- Publication type:
- Article
Tolerability of Isoniazid Preventive Therapy in an HIV-Infected Cohort of Paediatric and Adolescent Patients on Antiretroviral Therapy from a Resource-Limited Setting: A Retrospective Cohort Study.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 1, p. 37, doi. 10.1007/s40801-019-0147-3
- By:
- Publication type:
- Article
Characterization of Patients with Ankylosing Spondylitis Receiving Secukinumab and Reasons for Initiating Treatment: A US Physician Survey and Retrospective Medical Chart Review.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 1, p. 1, doi. 10.1007/s40801-018-0146-9
- By:
- Publication type:
- Article